D
Artivion, Inc.
AORT
$22.98
-$1.16-4.81%
D
Sell
2/6/2024Upgraded
Artivion, Inc. (AORT) was upgraded to D- from E+ on 2/6/2024 due to an increase in the total return index and valuation index.
Artivion, Inc. (AORT) was upgraded to D- from E+ on 2/6/2024 due to an increase in the total return index and valuation index.
E
Sell
12/12/2023Downgrade
Artivion, Inc. (AORT) was downgraded to E+ from D- on 12/12/2023 due to a decline in the valuation index and volatility index.
Artivion, Inc. (AORT) was downgraded to E+ from D- on 12/12/2023 due to a decline in the valuation index and volatility index.
D
Sell
11/27/2023Upgraded
Artivion, Inc. (AORT) was upgraded to D- from E+ on 11/27/2023 due to an increase in the volatility index and total return index.
Artivion, Inc. (AORT) was upgraded to D- from E+ on 11/27/2023 due to an increase in the volatility index and total return index.
E
Sell
11/9/2023Downgrade
Artivion, Inc. (AORT) was downgraded to E+ from D- on 11/9/2023 due to a decline in the valuation index and volatility index.
Artivion, Inc. (AORT) was downgraded to E+ from D- on 11/9/2023 due to a decline in the valuation index and volatility index.
D
Sell
5/8/2023Upgraded
Artivion, Inc. (AORT) was upgraded to D- from E+ on 5/8/2023 due to an increase in the total return index, volatility index and valuation index.
Artivion, Inc. (AORT) was upgraded to D- from E+ on 5/8/2023 due to an increase in the total return index, volatility index and valuation index.
E
Sell
3/14/2023Downgrade
Artivion, Inc. (AORT) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 2.23 to 2.19.
Artivion, Inc. (AORT) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 2.23 to 2.19.
D
Sell
5/16/2022Upgraded
Artivion, Inc. (AORT) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
Artivion, Inc. (AORT) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/13/2022Downgrade
Artivion, Inc. (AORT) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
Artivion, Inc. (AORT) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
4/21/2022Upgraded
Artivion, Inc. (AORT) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
Artivion, Inc. (AORT) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
E
Sell
4/20/2022Downgrade
Artivion, Inc. (AORT) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the growth index, solvency index and total return index. EBIT declined 802.8% from -$536 to -$4.84M, earnings per share declined from $0.2575 to -$0.51, and debt to equity increased from 1 to 1.04.
Artivion, Inc. (AORT) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the growth index, solvency index and total return index. EBIT declined 802.8% from -$536 to -$4.84M, earnings per share declined from $0.2575 to -$0.51, and debt to equity increased from 1 to 1.04.
D
Sell
9/13/2021Downgrade
CryoLife, Inc. (CRY) was downgraded to D from D+ on 9/13/2021 due to a decline in the volatility index and total return index.
CryoLife, Inc. (CRY) was downgraded to D from D+ on 9/13/2021 due to a decline in the volatility index and total return index.
D
Sell
8/2/2021Upgraded
CryoLife, Inc. (CRY) was upgraded to D+ from D on 8/2/2021 due to a large increase in the growth index, volatility index and total return index. Operating cash flow increased 187.1% from -$3.04M to $2.65M, EBIT increased 91.35% from $2.42M to $4.62M, and earnings per share increased from -$0.0804 to -$0.06.
CryoLife, Inc. (CRY) was upgraded to D+ from D on 8/2/2021 due to a large increase in the growth index, volatility index and total return index. Operating cash flow increased 187.1% from -$3.04M to $2.65M, EBIT increased 91.35% from $2.42M to $4.62M, and earnings per share increased from -$0.0804 to -$0.06.
D
Sell
3/20/2020Downgrade
CryoLife, Inc. (CRY) was downgraded to D from D+ on 3/20/2020 due to a noticeable decline in the growth index, volatility index and efficiency index. Net income declined 408.21% from -$134 to -$681, earnings per share declined from -$0.0036 to -$0.0181, and operating cash flow declined 91.76% from $12.86M to $1.06M.
CryoLife, Inc. (CRY) was downgraded to D from D+ on 3/20/2020 due to a noticeable decline in the growth index, volatility index and efficiency index. Net income declined 408.21% from -$134 to -$681, earnings per share declined from -$0.0036 to -$0.0181, and operating cash flow declined 91.76% from $12.86M to $1.06M.
D
Sell
10/21/2019Downgrade
CryoLife, Inc. (CRY) was downgraded to D+ from C- on 10/21/2019 due to a major decline in the total return index and volatility index.
CryoLife, Inc. (CRY) was downgraded to D+ from C- on 10/21/2019 due to a major decline in the total return index and volatility index.
C
Hold
5/1/2019Upgraded
CryoLife, Inc. (CRY) was upgraded to C- from D+ on 5/1/2019 due to a noticeable increase in the total return index.
CryoLife, Inc. (CRY) was upgraded to C- from D+ on 5/1/2019 due to a noticeable increase in the total return index.
D
Sell
2/28/2019Downgrade
CryoLife, Inc. (CRY) was downgraded to D+ from C- on 2/28/2019 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0412 to -$0.021.
CryoLife, Inc. (CRY) was downgraded to D+ from C- on 2/28/2019 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0412 to -$0.021.
C
Hold
12/13/2018Downgrade
CryoLife, Inc. (CRY) was downgraded to C- from C on 12/13/2018 due to a significant decline in the efficiency index, total return index and valuation index.
CryoLife, Inc. (CRY) was downgraded to C- from C on 12/13/2018 due to a significant decline in the efficiency index, total return index and valuation index.
C
Hold
11/2/2017Downgrade
CryoLife, Inc. (CRY) was downgraded to C from B- on 11/2/2017 due to a significant decline in the growth index, total return index and valuation index. EBIT declined 82.02% from $4.79M to $861, earnings per share declined from $0.0918 to $0.0396, and total revenue declined 7.99% from $47.82M to $44M.
CryoLife, Inc. (CRY) was downgraded to C from B- on 11/2/2017 due to a significant decline in the growth index, total return index and valuation index. EBIT declined 82.02% from $4.79M to $861, earnings per share declined from $0.0918 to $0.0396, and total revenue declined 7.99% from $47.82M to $44M.
B
Buy
9/5/2017Downgrade
CryoLife, Inc. (CRY) was downgraded to B- from B on 9/5/2017 due to a decline in the valuation index and total return index.
CryoLife, Inc. (CRY) was downgraded to B- from B on 9/5/2017 due to a decline in the valuation index and total return index.
B
Buy
8/7/2017Upgraded
CryoLife, Inc. (CRY) was upgraded to B from B- on 8/7/2017 due to a major increase in the total return index, growth index and volatility index. Earnings per share increased from $0.0649 to $0.0918, total revenue increased 6.12% from $45.06M to $47.82M, and EBIT increased 5.28% from $4.55M to $4.79M.
CryoLife, Inc. (CRY) was upgraded to B from B- on 8/7/2017 due to a major increase in the total return index, growth index and volatility index. Earnings per share increased from $0.0649 to $0.0918, total revenue increased 6.12% from $45.06M to $47.82M, and EBIT increased 5.28% from $4.55M to $4.79M.
B
Buy
7/5/2017Upgraded
CryoLife, Inc. (CRY) was upgraded to B- from C+ on 7/5/2017 due to a noticeable increase in the total return index, growth index and solvency index. EBIT increased 608.16% from -$895 to $4.55M, the quick ratio increased from 2.88 to 3.09, and debt to equity declined from 0.34 to 0.33.
CryoLife, Inc. (CRY) was upgraded to B- from C+ on 7/5/2017 due to a noticeable increase in the total return index, growth index and solvency index. EBIT increased 608.16% from -$895 to $4.55M, the quick ratio increased from 2.88 to 3.09, and debt to equity declined from 0.34 to 0.33.
C
Hold
2/23/2017Downgrade
CryoLife, Inc. (CRY) was downgraded to C+ from B- on 2/23/2017 due to a decline in the total return index and volatility index.
CryoLife, Inc. (CRY) was downgraded to C+ from B- on 2/23/2017 due to a decline in the total return index and volatility index.
B
Buy
2/21/2017Downgrade
CryoLife, Inc. (CRY) was downgraded to B- from B on 2/21/2017 due to a large decline in the growth index, total return index and valuation index. EBIT declined 114.38% from $6.23M to -$895, operating cash flow declined 42.9% from $8.84M to $5.05M, and earnings per share declined from $0.0886 to $0.085.
CryoLife, Inc. (CRY) was downgraded to B- from B on 2/21/2017 due to a large decline in the growth index, total return index and valuation index. EBIT declined 114.38% from $6.23M to -$895, operating cash flow declined 42.9% from $8.84M to $5.05M, and earnings per share declined from $0.0886 to $0.085.
B
Buy
9/1/2016Upgraded
CryoLife Inc. (CRY) was upgraded to B from B- on 9/1/2016 due to an increase in the total return index and volatility index.
CryoLife Inc. (CRY) was upgraded to B from B- on 9/1/2016 due to an increase in the total return index and volatility index.
B
Buy
8/17/2016Downgrade
CryoLife Inc. (CRY) was downgraded to B- from B on 8/17/2016 due to a large decline in the total return index and valuation index.
CryoLife Inc. (CRY) was downgraded to B- from B on 8/17/2016 due to a large decline in the total return index and valuation index.
B
Buy
7/28/2016Upgraded
CryoLife Inc. (CRY) was upgraded to B from B- on 7/28/2016 due to a substantial increase in the total return index, growth index and valuation index. Operating cash flow increased 214.04% from $1.41M to $4.43M, EBIT increased 34.37% from $4.9M to $6.59M, and total revenue increased 9.45% from $43.02M to $47.08M.
CryoLife Inc. (CRY) was upgraded to B from B- on 7/28/2016 due to a substantial increase in the total return index, growth index and valuation index. Operating cash flow increased 214.04% from $1.41M to $4.43M, EBIT increased 34.37% from $4.9M to $6.59M, and total revenue increased 9.45% from $43.02M to $47.08M.
B
Buy
5/2/2016Upgraded
CryoLife Inc. (CRY) was upgraded to B- from C on 5/2/2016 due to a major increase in the growth index, valuation index and total return index. Total revenue increased 7.98% from $39.84M to $43.02M.
CryoLife Inc. (CRY) was upgraded to B- from C on 5/2/2016 due to a major increase in the growth index, valuation index and total return index. Total revenue increased 7.98% from $39.84M to $43.02M.
C
Hold
9/10/2015Downgrade
CryoLife Inc. (CRY) was downgraded to C from C+ on 9/10/2015 due to a major decline in the volatility index and total return index.
CryoLife Inc. (CRY) was downgraded to C from C+ on 9/10/2015 due to a major decline in the volatility index and total return index.
C
Hold
8/14/2015Upgraded
CryoLife Inc. (CRY) was upgraded to C+ from C on 8/14/2015 due to an increase in the total return index and valuation index.
CryoLife Inc. (CRY) was upgraded to C+ from C on 8/14/2015 due to an increase in the total return index and valuation index.
C
Hold
7/30/2015Downgrade
CryoLife Inc. (CRY) was downgraded to C from C+ on 7/30/2015 due to a noticeable decline in the valuation index, volatility index and efficiency index.
CryoLife Inc. (CRY) was downgraded to C from C+ on 7/30/2015 due to a noticeable decline in the valuation index, volatility index and efficiency index.
C
Hold
5/1/2015Downgrade
CryoLife Inc. (CRY) was downgraded to C+ from B- on 5/1/2015 due to a decline in the growth index, total return index and volatility index. EBIT declined 181.57% from $1.91M to -$1.55M, earnings per share declined from $0.0612 to -$0.01, and operating cash flow declined 72.87% from $4.79M to $1.3M.
CryoLife Inc. (CRY) was downgraded to C+ from B- on 5/1/2015 due to a decline in the growth index, total return index and volatility index. EBIT declined 181.57% from $1.91M to -$1.55M, earnings per share declined from $0.0612 to -$0.01, and operating cash flow declined 72.87% from $4.79M to $1.3M.
B
Buy
2/20/2015Downgrade
CryoLife Inc. (CRY) was downgraded to B- from B+ on 2/20/2015 due to a significant decline in the valuation index, growth index and efficiency index. EBIT declined 36.82% from $3.02M to $1.91M, earnings per share declined from $0.0804 to $0.0612, and net income declined 23.65% from $2.33M to $1.78M.
CryoLife Inc. (CRY) was downgraded to B- from B+ on 2/20/2015 due to a significant decline in the valuation index, growth index and efficiency index. EBIT declined 36.82% from $3.02M to $1.91M, earnings per share declined from $0.0804 to $0.0612, and net income declined 23.65% from $2.33M to $1.78M.
B
Buy
1/6/2015Downgrade
CryoLife Inc. (CRY) was downgraded to B+ from A- on 1/6/2015 due to a decline in the total return index, valuation index and volatility index.
CryoLife Inc. (CRY) was downgraded to B+ from A- on 1/6/2015 due to a decline in the total return index, valuation index and volatility index.
A
Buy
10/31/2014Downgrade
CryoLife Inc. (CRY) was downgraded to A- from A on 10/31/2014 due to a substantial decline in the growth index, valuation index and efficiency index. Operating cash flow declined 12.66% from $2.87M to $2.5M.
CryoLife Inc. (CRY) was downgraded to A- from A on 10/31/2014 due to a substantial decline in the growth index, valuation index and efficiency index. Operating cash flow declined 12.66% from $2.87M to $2.5M.
A
Buy
9/29/2014Upgraded
CryoLife Inc. (CRY) was upgraded to A from A- on 9/29/2014 due to an increase in the volatility index and total return index.
CryoLife Inc. (CRY) was upgraded to A from A- on 9/29/2014 due to an increase in the volatility index and total return index.
A
Buy
9/18/2014Upgraded
CryoLife Inc. (CRY) was upgraded to A- from B+ on 9/18/2014 due to an increase in the volatility index, total return index and valuation index.
CryoLife Inc. (CRY) was upgraded to A- from B+ on 9/18/2014 due to an increase in the volatility index, total return index and valuation index.
B
Buy
9/2/2014Downgrade
CryoLife Inc. (CRY) was downgraded to B+ from A- on 9/2/2014 due to a noticeable decline in the volatility index.
CryoLife Inc. (CRY) was downgraded to B+ from A- on 9/2/2014 due to a noticeable decline in the volatility index.
A
Buy
8/18/2014Upgraded
CryoLife Inc. (CRY) was upgraded to A- from B+ on 8/18/2014 due to an increase in the volatility index.
CryoLife Inc. (CRY) was upgraded to A- from B+ on 8/18/2014 due to an increase in the volatility index.
B
Buy
8/1/2014Downgrade
CryoLife Inc. (CRY) was downgraded to B+ from A- on 8/1/2014 due to a decline in the volatility index and valuation index.
CryoLife Inc. (CRY) was downgraded to B+ from A- on 8/1/2014 due to a decline in the volatility index and valuation index.
A
Buy
7/14/2014Upgraded
CryoLife Inc. (CRY) was upgraded to A- from B on 7/14/2014 due to a large increase in the volatility index.
CryoLife Inc. (CRY) was upgraded to A- from B on 7/14/2014 due to a large increase in the volatility index.
B
Buy
7/8/2014Downgrade
CryoLife Inc. (CRY) was downgraded to B from B+ on 7/8/2014 due to a decline in the volatility index.
CryoLife Inc. (CRY) was downgraded to B from B+ on 7/8/2014 due to a decline in the volatility index.
B
Buy
7/3/2014Downgrade
CryoLife Inc. (CRY) was downgraded to B+ from A- on 7/3/2014 due to a decline in the volatility index and valuation index.
CryoLife Inc. (CRY) was downgraded to B+ from A- on 7/3/2014 due to a decline in the volatility index and valuation index.
A
Buy
6/2/2014Downgrade
CryoLife Inc. (CRY) was downgraded to A- from A on 6/2/2014 due to a decline in the volatility index, growth index and efficiency index. Operating cash flow declined 137.29% from $5.47M to -$2.04M, net income declined 88.27% from $9.03M to $1.06M, and earnings per share declined from $0.3129 to $0.0379.
CryoLife Inc. (CRY) was downgraded to A- from A on 6/2/2014 due to a decline in the volatility index, growth index and efficiency index. Operating cash flow declined 137.29% from $5.47M to -$2.04M, net income declined 88.27% from $9.03M to $1.06M, and earnings per share declined from $0.3129 to $0.0379.
A
Buy
3/24/2014Upgraded
CryoLife Inc. (CRY) was upgraded to A from A- on 3/24/2014 due to an increase in the volatility index, solvency index and valuation index.
CryoLife Inc. (CRY) was upgraded to A from A- on 3/24/2014 due to an increase in the volatility index, solvency index and valuation index.
NYSE
04/04/2025 12:46PM Eastern
Quotes delayed
